AIMS/HYPOTHESIS: The aim of this study was to use lipidomics to determine if the lipid composition of apolipoprotein-B-containing lipoproteins is modified by dyslipidaemia in type 2 diabetes and if any of the identified changes potentially have biological relevance in the pathophysiology of type 2 diabetes. METHODS: VLDL and LDL from normolipidaemic and dyslipidaemic type 2 diabetic women and controls were isolated and quantified with HPLC and mass spectrometry. A detailed molecular characterisation of VLDL triacylglycerols (TAG) was also performed using the novel ozone-induced dissociation method, which allowed us to distinguish vaccenic acid (C18:1 n-7) from oleic acid (C18:1 n-9) in specific TAG species. RESULTS: Lipid class composition was very similar in VLDL and LDL from normolipidaemic type 2 diabetic and control participants. By contrast, dyslipidaemia was associated with significant changes in both lipid classes (e.g. increased diacylglycerols) and lipid species (e.g. increased C16:1 and C20:3 in phosphatidylcholine and cholesteryl ester and increased C16:0 [palmitic acid] and vaccenic acid in TAG). Levels of palmitic acid in VLDL and LDL TAG correlated with insulin resistance, and VLDL TAG enriched in palmitic acid promoted increased secretion of proinflammatory mediators from human smooth muscle cells. CONCLUSIONS: We showed that dyslipidaemia is associated with major changes in both lipid class and lipid species composition in VLDL and LDL from women with type 2 diabetes. In addition, we identified specific molecular lipid species that both correlate with clinical variables and are proinflammatory. Our study thus shows the potential of advanced lipidomic methods to further understand the pathophysiology of type 2 diabetes.
AIMS/HYPOTHESIS: The aim of this study was to use lipidomics to determine if the lipid composition of apolipoprotein-B-containing lipoproteins is modified by dyslipidaemia in type 2 diabetes and if any of the identified changes potentially have biological relevance in the pathophysiology of type 2 diabetes. METHODS: VLDL and LDL from normolipidaemic and dyslipidaemic type 2 diabeticwomen and controls were isolated and quantified with HPLC and mass spectrometry. A detailed molecular characterisation of VLDL triacylglycerols (TAG) was also performed using the novel ozone-induced dissociation method, which allowed us to distinguish vaccenic acid (C18:1 n-7) from oleic acid (C18:1 n-9) in specific TAG species. RESULTS:Lipid class composition was very similar in VLDL and LDL from normolipidaemic type 2 diabetic and control participants. By contrast, dyslipidaemia was associated with significant changes in both lipid classes (e.g. increased diacylglycerols) and lipid species (e.g. increased C16:1 and C20:3 in phosphatidylcholine and cholesteryl ester and increased C16:0 [palmitic acid] and vaccenic acid in TAG). Levels of palmitic acid in VLDL and LDL TAG correlated with insulin resistance, and VLDL TAG enriched in palmitic acid promoted increased secretion of proinflammatory mediators from human smooth muscle cells. CONCLUSIONS: We showed that dyslipidaemia is associated with major changes in both lipid class and lipid species composition in VLDL and LDL from women with type 2 diabetes. In addition, we identified specific molecular lipid species that both correlate with clinical variables and are proinflammatory. Our study thus shows the potential of advanced lipidomic methods to further understand the pathophysiology of type 2 diabetes.
Authors: Gerhard Brohall; Carl-Johan Behre; Johannes Hulthe; John Wikstrand; Björn Fagerberg Journal: Diabetes Care Date: 2006-02 Impact factor: 19.112
Authors: A Kotronen; V R Velagapudi; L Yetukuri; J Westerbacka; R Bergholm; K Ekroos; J Makkonen; M-R Taskinen; M Oresic; H Yki-Järvinen Journal: Diabetologia Date: 2009-02-13 Impact factor: 10.122
Authors: Marcus Ståhlman; Christer S Ejsing; Kirill Tarasov; Jeanna Perman; Jan Borén; Kim Ekroos Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2009-02-24 Impact factor: 3.205
Authors: C Pettersson; L Fogelstrand; B Rosengren; S Ståhlman; E Hurt-Camejo; B Fagerberg; O Wiklund Journal: J Intern Med Date: 2008-02-20 Impact factor: 8.989
Authors: G D Norata; L Grigore; S Raselli; P M Seccomandi; A Hamsten; F M Maggi; P Eriksson; A L Catapano Journal: J Mol Cell Cardiol Date: 2006-03-06 Impact factor: 5.000
Authors: Simon H J Brown; Todd W Mitchell; Aaron J Oakley; Huong T Pham; Stephen J Blanksby Journal: J Am Soc Mass Spectrom Date: 2012-06-06 Impact factor: 3.109
Authors: M John Chapman; Alexina Orsoni; Ricardo Tan; Natalie A Mellett; Anh Nguyen; Paul Robillard; Philippe Giral; Patrice Thérond; Peter J Meikle Journal: J Lipid Res Date: 2020-04-15 Impact factor: 5.922
Authors: Kelli M Sas; Jiahe Lin; Thekkelnaycke M Rajendiran; Tanu Soni; Viji Nair; Lucy M Hinder; Hosagrahar V Jagadish; Thomas W Gardner; Steven F Abcouwer; Frank C Brosius; Eva L Feldman; Matthias Kretzler; George Michailidis; Subramaniam Pennathur Journal: J Lipid Res Date: 2017-12-13 Impact factor: 5.922
Authors: Huong T Pham; Alan T Maccarone; J Larry Campbell; Todd W Mitchell; Stephen J Blanksby Journal: J Am Soc Mass Spectrom Date: 2013-01-05 Impact factor: 3.109
Authors: Omar M Khan; Murali K Akula; Kristina Skålen; Christin Karlsson; Marcus Ståhlman; Stephen G Young; Jan Borén; Martin O Bergo Journal: Circulation Date: 2013-01-18 Impact factor: 29.690